July 15, 2025

U.S. Children’s Health Worsens Over 17 Years

A new study analyzing over a decade of national health surveys, electronic records, and international data shows a consistent rise in chronic conditions, obesity, emotional symptoms, and mortality rates among children and adolescents in the U.S..

Conexiant

July 10, 2025

1 in 4 U.S. Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 08, 2025

EVOO, Petrolatum Both Improve Skin Barrier Metrics

A clinical trial in healthy adults found that both extra virgin olive oil and petrolatum significantly improved skin hydration and barrier function, with differing effects on water loss and skin cell turnover.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Herbal Emollient Shows Lasting Relief for Eczema

Clinical trial finds herbal emollients with ginger and cannabidiol reduce itch, improve symptoms, and restore skin barrier in mild atopic dermatitis.

Conexiant

June 25, 2025

AD Itch: A Ten-Year Overview

A decade-long analysis tracked global trends, key authors, drug developments, and growing research volume in studies focused on atopic dermatitis-related itch.

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant